Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Antidepressants in Pregnancy Increase Risk of Miscarriage

By LabMedica International staff writers
Posted on 07 Jun 2010
A new study has found a 68% increase in the overall risk of miscarriage in pregnant women using antidepressants.

Researchers from the University of Montreal (Canada) and the CHU Ste-Justine (Montreal, Canada) examined data on 5,124 women in Quebec (Canada) from a large population-based cohort of pregnant women who had clinically verified miscarriages at up to 20 weeks of gestation, and a large sample of women from the same registry who did not have a miscarriage. More...
Of those who miscarried, 284 (5.5%) had taken antidepressants during pregnancy.

The researchers found that selective serotonin reuptake inhibitors (SSRIs), especially paroxetine and venlafaxine, were associated with increased risk of miscarriage, as were higher daily doses of either antidepressant; a combination of different antidepressants further doubled the risk of miscarriages. The researchers urged physicians who have patients of childbearing age taking antidepressants, or pregnant patients who require antidepressant therapy early in pregnancy, to discuss the risks and benefits with them. The study was published in the June 2010 issue of the Canadian Medical Association Journal (CMAJ).

"These results, which suggest an overall class effect of selective serotonin reuptake inhibitors, are highly robust given the large number of users studied,” said senior author Anick Bérard, Ph.D., and colleagues of the faculty of pharmacy at the University of Montreal.

SSRIs are typically used in the treatment of depression, anxiety disorders, and some personality disorders. They are also typically effective and used in treating premature ejaculation problems as well as some cases of insomnia. SSRIs increase the extracellular level of the neurotransmitter serotonin by inhibiting its reuptake into the presynaptic cell, increasing the level of serotonin available to bind to the postsynaptic receptor.

Related Links:

University of Montreal
CHU Ste-Justine




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.